PKCι is a target of 7,8,4'-trihydroxyisoflavone for the suppression of UVB-induced MMP-1 expression

Tae-Gyu Lim1,2,3,4, Yoon-A Kim1,3, Jong-Eun Kim5

  • 1WCU Biomodulation Major, Department of Agricultural Biotechnology, Seoul National University, Seoul, Korea.

Insights

7,8,4'-trihydroxyisoflavone (7,8,4'-THIF), derived from soy isoflavone daidzein, effectively inhibits UVB-induced matrix metalloproteinase-1 (MMP-1) expression by targeting key signaling pathways in skin cells.

Area of Science:

  • Biochemistry
  • Dermatology
  • Molecular Biology

Background:

  • Soy isoflavones, like daidzein, undergo microbial bioconversion to bioactive compounds.
  • Matrix metalloproteinase-1 (MMP-1) plays a significant role in skin aging and photodamage.
  • Understanding the molecular mechanisms behind MMP-1 regulation is crucial for developing photoprotective strategies.

Discussion:

  • 7,8,4'-trihydroxyisoflavone (7,8,4 zez-THIF) demonstrates potent inhibition of UVB-induced MMP-1 expression.
  • This inhibition occurs at the transcriptional level, impacting AP-1 activation and MAPK signaling.
  • Protein kinase C iota (PKCι) is identified as a direct molecular target of 7,8,4 zez-THIF.

Key Insights:

  • 7,8,4 zez-THIF suppresses UVB-induced MMP-1 expression in human dermal fibroblasts.
  • The compound modulates the AP-1 and MAPK signaling pathways, crucial for MMP-1 gene activation.
  • Direct interaction between 7,8,4 zez-THIF and PKCι was experimentally confirmed.

Outlook:

  • 7,8,4 zez-THIF shows promise as a therapeutic agent for mitigating UVB-induced skin damage.
  • Further research could explore its efficacy in vivo and its potential applications in cosmetic and dermatological formulations.
  • Investigating downstream effects of PKCι inhibition by 7,8,4 zez-THIF may reveal additional therapeutic benefits.